European Organisation for Research and Treatment of Cancer - EORTC: Neoplasms trials
The registry lists 19 Neoplasms studies with European Organisation for Research and Treatment of Cancer - EORTC as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 1 13Phase 2 2Phase 3 2No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- SPECTA: Screening Cancer Patients for Efficient Clinical Trial AccessRecruitingNCT02834884
- Diffusion-Weighted MRI for Liver MetastasisCompletedNCT02781935
- Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With CancerTerminatedNCT00062231Not applicable
- Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid TumorsCompletedNCT00027677Phase 1
- Mistletoe Lectin in Treating Patients With Refractory Advanced Solid TumorsCompletedNCT00006477Phase 1
- Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous TherapyCompletedNCT00006354Phase 1
- Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid TumorsCompletedNCT00005061Phase 1
- MS 209 Plus Docetaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00004886Phase 1
- KRN7000 in Treating Patients With Solid TumorsWithdrawnNCT00003985Phase 1
- MEN-10755 in Treating Patients With Solid TumorsCompletedNCT00003982Phase 1
- E7070 in Treating Patients With Solid TumorsCompletedNCT00003981Phase 1
- BIBX 1382 in Treating Patients With Solid TumorsSuspendedNCT00003980Phase 1
- CHS 828 in Treating Patients With Solid TumorsWithdrawnNCT00003979Phase 1
- E7070 in Treating Patients With Solid TumorsCompletedNCT00003976Phase 1
- Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell CountCompletedNCT00003805Phase 3
- Combination Chemotherapy in Treating Men With Germ Cell CancerStatus unknownNCT00003643Phase 2/3
- MEN-10755 in Treating Adults With Recurrent or Refractory Solid TumorsCompletedNCT00003028Phase 1
- Ecteinascidin 743 in Treating Adults With Advanced Solid TumorsCompletedNCT00002904Phase 1
- Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell CancerCompletedNCT00002903Phase 2